Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F13UM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,507
Award facts
- Contract value 100% obligated
- $16,506.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,506.63 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Dupixent 300 mg/2 ml pens with a completion date of February 2, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 31, 2031. The performance location is listed as Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp.
Dupixent (dupilumab) is a biologic medication commonly prescribed for conditions including moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma. This procurement supports the Defense Health Agency's pharmaceutical supply chain and military healthcare system requirements. The underlying IDC with Cencora, Inc. serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and other critical medical supplies to military treatment facilities and federal healthcare programs worldwide, demonstrating the company's established capability to meet complex federal medical procurement needs through open and competitive contracting.
Quick answers
Who was awarded contract SPE2DR26F13UM?
SPE2DR26F13UM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F13UM worth?
The government has obligated $16,507 on SPE2DR26F13UM.
Is contract SPE2DR26F13UM an order under another contract?
Yes. SPE2DR26F13UM is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13UM competed?
The extent of competition for SPE2DR26F13UM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award